GENZYME - THE KING OF THE BIOTECHS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (281)	7/13/1998 7:59:00 PM
From: Caveat Emptor	of 410

Recent Insider Shift Information. Recent 13D filing of Paine Webber R+D Partners 11. Transfer of ownership of partnership interest to BIOROYALTIES LLC Research has found that Paine Webber R+D Partners 11 has been a significant stockholder and Investment Service of Genzyme since 1989. to review 13D sec.gov click into Edgar type - BIOROYALTIES at prompt Research this transaction, as well as previously filed 10K of Paine Webber R+D 11 for background of Genzyme Ownership. Any comments on this? More information to follow. CAVEAT EMPTOR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next